The article discusses how Big Pharma has prevented Medicare from negotiating lower drug prices for seniors, resulting in record profits for drug companies. However, President Biden and Congressional Democrats passed the Inflation Reduction Act, which allows Medicare to negotiate lower prices. Despite opposition from Republicans and Big Pharma, a ruling from the Southern District of Ohio affirms that Medicare will proceed with negotiating lower prices. The article emphasizes that there is nothing in the Constitution that prohibits Medicare from negotiating drug prices. The Biden-Harris Administration aims to lower healthcare costs for American families and ensure that prescription drug costs decrease for conditions such as heart failure, blood clots, diabetes, and arthritis. The article concludes by stating that Americans should not have to pay significantly more for prescription drugs compared to other developed nations, and the administration will continue to fight for lower healthcare costs despite challenges from Republicans and Big Pharma.